Lanxess (ETR:LXS) has been assigned a €73.00 ($86.90) price objective by analysts at Independent Research in a report released on Friday. The brokerage currently has a “neutral” rating on the stock. Independent Research’s target price would suggest a potential upside of 5.74% from the stock’s current price.
Several other brokerages also recently weighed in on LXS. Macquarie set a €75.00 ($89.29) price objective on shares of Lanxess and gave the stock a “buy” rating in a research report on Thursday, September 7th. Societe Generale set a €67.00 ($79.76) target price on shares of Lanxess and gave the company a “neutral” rating in a report on Thursday, September 7th. Nord/LB set a €72.00 ($85.71) target price on shares of Lanxess and gave the company a “buy” rating in a report on Thursday, September 7th. DZ Bank reaffirmed a “buy” rating on shares of Lanxess in a report on Friday, September 8th. Finally, Baader Bank set a €75.00 ($89.29) target price on shares of Lanxess and gave the company a “buy” rating in a report on Monday, September 11th. Thirteen investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of €70.80 ($84.29).
Lanxess (ETR LXS) traded up €1.44 ($1.71) during trading hours on Friday, reaching €69.04 ($82.19). The company’s stock had a trading volume of 299,442 shares, compared to its average volume of 351,340. Lanxess has a 12-month low of €59.89 ($71.30) and a 12-month high of €70.67 ($84.13). The company has a market capitalization of $6,320.00 and a price-to-earnings ratio of 45.72.
LANXESS Aktiengesellschaft develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in four segments: Advanced Intermediates, Performance Chemicals, High Performance Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemicals and coatings industries; fine chemicals as precursors and intermediates for pharmaceuticals, agrochemicals, and specialty chemicals industries; customer-specific specialties; and tire chemicals.
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.